Biobank Market By Specimens Type (Blood Products, Cell Lines, Nucleic Acids And Human Tissues), By Region And By Trends - Global Forecast to 2023      

Starting Price : $ 4000.00 | Pages : 154 | Published : March 2019 | SKU CODE : o&s076 | Format :

Request Sample

Biobanks Market Definition

The biobanks market consists of sales of biological specimens such as blood products, human tissues, cell lines nucleic acids (DNA, RNA) and other specimens through biorepositories. This market does not include sales generated from the sale of blood to be used for transfusions to treat medical conditions or of statistical information such as age, gender, diet and lifestyles which biobanks collect.

A biobank is a collection of human biological specimens including whole organs, tissue, blood products, plasma, urine, or intracellular components such as DNA and RNA. Biobanks are also known as bio-repositories, bio-resources or tissue banks. The primary function of biobanks is to collect, analyze, store and distribute bio-specimens for research purposes and for treating medical conditions.  They can be established within academic, medical or research institutions, pharmaceutical/biotechnology companies, hospitals or as stand-alone organizations.

Biobanks Market Size

The biobanks market reached a value of nearly $50.3 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% to nearly $68.5 billion by 2023.

Factors such as advances in drug discovery and development, rise in funding from government and private organizations, changes in lifestyle and increasing geriatric population globally are contributing to the growth of the market.

Factors such as such as stringent regulations, lack of standardization and ethical and legal issues such as informed consent and protection of participant privacy may restrain the growth of the biobanks market.

Biobanks Market Drivers

The key drivers of the biobanks market includes:

Rise in Genomic and Proteomic Research – Increase in genomic and proteomic research is expected to drive the biobank market during the forecast period. Genomics involves the study of all genes and proteomics is a study of a set of proteins.  Biobanks consist of bio specimens required during the genomic and proteomic research. It aids in identification of genomic variations associated with the diseases. In 2018, Cleveland Clinics and Brooks Automation partnered to introduce a new biobank that will advance genomic research and improve clinical care.  In 2018, UK Biobank announced a major initiative to sequence the genomes of 50,000 UK Biobank volunteer participants.

Biobanks Market Restraints

The key restraints on the biobanks market include:

Regulatory Hurdles – Stringent regulations relating to biobanks will be a major restraint on the market during the forecast period. Regulations related to the privacy of individuals or research participants with effective research is a challenge. For example, in 2018, the new European Union (EU) General Data Protection Regulation (GDPR) made privacy policies more consistent across the EU (including the UK) for personal data such as genetic and clinical information. The new law states that only necessary data should be collected and held for a short time. Also, a Data Protection Officer (DPO) is required for monitoring large volumes of data. These regulatory policies are expected to be a major restraint on the biobanks market in the forecast period.

Biobanks Market Trends

Major trends influencing the biobanks market include:

Automated Sample Storage and Liquid Handling Systems in Biobanks – Automated sample storage and liquid handling systems are increasingly being used by biobanks to accommodate   large number of samples, maintain sample integrity and enhance accessibility.  For example, Mayo Clinic Biobank Infrastructure in the USA has automated sample storage and liquid handling systems following a design by Hamilton Storage and Hamilton Robotics. The system can manage and store up to 8.7 million biological samples at minus 80 °C.  This technology aids in accurate tracking, storing, and retrieving samples. Lifelines’ biobank in the Netherlands is using automated sample storage and liquid handling systems to standardize sample collection and maintain sample integrity. Samples were stored in a Hamilton Bios system which has the capacity to store up to 10 million sample tubes at minus 80°C.

Development of Virtual Biobanks – Traditional biobanks are offering virtual biobanks to aid biomedical research. A virtual biobank is an online platform which provides 2D and 3D form of samples stored at traditional biobanks. It can be accessed via specialized software or a web portal. This tool helps to speed up the accessibility of bio specimens and clinical data, and further analyze samples. In 2018, a virtual biobank was developed by the UK’s University of Newcastle and Australia’s Hunter Medical Research Institute to host 3D copies of human cancer tissues. This online platform allows researchers to access virtual copies of tumor samples from the Hunter Cancer Biobank, along with important clinical and molecular information. It will accelerate cancer research activities. The University of California San Francisco (UCSF) is developing a virtual biobank which will be widely available to UCSF investigators. It will provide aggregate participant and sample data for existing bio specimen collections from participating repositories. It will promote collaborations and enhance research due to the accessibility of pre-existing bio specimens.

Opportunities In The Biobanks Market

Opportunities – The top opportunities in the global biobanks market will arise in the USA, where the market will gain $4,543 million in annual sales between 2018 and 2023, in China, where it will put on $3,488 million and globally, where the blood products segment will accrue $10,385 of extra revenues in that period. To take advantage of such opportunities, biobank businesses should adopt strategies such as developing virtual banks to speed up the accessibility of bio specimen and clinical data, implementing radio frequency identification (RFID) technology to automate bio specimen sample tagging and tracking and help reduce costs and errors and building resource centers of biological samples for major diseases.

Biobanks Market Segmentation

The Biobanks market is categorized by segment, and by geography.
By Segment - The biobanks market is categorized by segment into
    • a) Blood Products
    • b) Cell Lines
    • c) Nucleic Acids
    • d) Human Tissues and Cells
The blood products segment accounted for the largest share of the biobanks market in 2018 at $38.1 billion. The highest growth is projected to come from the human tissues and cells segment, which is forecast to grow at a CAGR of 12.3%. This growth was mainly due to greater use of blood products such as plasma and platelets for treating medical conditions and for medical research.
By Geography - The biobanks market is segmented into
    • o North America
      • USA
    • o Western Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
    • o Asia Pacific
      • China
      • Japan
      • India
      • Australia
    • o Eastern Europe
      • Russia
    • o South America
      • Brazil
    • o Middle East
    • o Africa
North America was the largest region in the biobanks market in 2018, accounting for 46.8% of the global market. It was followed by Western Europe and Asia Pacific. Going forward, the fastest growth in the biobanks market will take place in Asia Pacific, followed by South America.

Biobanks Competitive Landscape

Major Competitors are:
    • • Japanese Red Cross Society
    • • American Red Cross
    • • Canadian Blood Services
    • • Biobank Graz
    • • Shanghai Zhangjiang Biobank

  1. 1.Executive Summary
  2. 2.Table of Contents
  3. 3.List of Figures
  4. 4.List of Tables
  5. 5.Report Structure
  6. 6.Introduction
  7. 7.Biobanks Market Characteristics
  8. 8.Biobanks Market – Supply Chain
  9. 9.Biobanks Market Industry Trends and Strategies
    • 9.1.Development of Virtual Biobanks
    • 9.2.Radio Frequency Identification (RFID) for Sample Tracking
    • 9.3.Automated Sample Storage and Liquid Handling Systems in Biobanks
    • 9.4.Use of Dry Storage as an Alternative by Biobanks
    • 9.5.Use of Internet of Things (IOT) and Big Data Analytics in Biobanks
    • 9.6.Increase in Collaborations and Partnerships
  10. 10.Biobanks Market Size and Growth
    • 10.1.Historic Market Growth
    • 10.2.Drivers of the Market
    • 10.3.Restraints on the Market
    • 10.4.Drivers of the Market
    • 10.5.Restraints on the Market
  11. 11.Biobanks Market Regional and Country Analysis
    • 11.1.Global Biobanks Market, By Region
    • 11.2.Global Biobanks Market, 2014-2023, Historic and Forecast, By Region
    • 11.3.Global Biobanks Market, By Country
    • 11.4.Global Biobanks Market, 2014-2023, Historic and Forecast, By Country
  12. 12.Biobanks Market Segmentation
    • 12.1.Global Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 12.2.Global Biobanks Market, 2014-2023, Historic and Forecast, By Segment
  13. 13.Global Biobanks Market Comparison with Macro Economic Factors
    • 13.1.Global Per Capita Average Biobanks Market Expenditure
    • 13.2.Per Capita Average Biobanks Market Expenditure, By Country
    • 13.3.Global Biobanks Market Size, Percentage of GDP
    • 13.4.Biobanks Market Size, Percentage of GDP, By Country
  14. 14.Asia-Pacific Biobanks Market
    • 14.1.Asia-Pacific Biobanks Market Overview
      • 14.1.1.Region Information
      • 14.1.2.Market Information
      • 14.1.3.Background Information
      • 14.1.4.Associations
      • 14.1.5.Regulation
      • 14.1.6.Regulatory Bodies
      • 14.1.7.Corporate Tax Structure
      • 14.1.8.Investments
      • 14.1.9.Major Companies
      • 14.1.10.End User Information
    • 14.2.Asia-Pacific Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 14.3.Asia-Pacific Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 14.4.Asia-Pacific Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 14.5.Asia-Pacific Biobanks Market: Country Analysis
    • 14.6.China Biobanks Market
    • 14.7.China Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 14.8.China Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 14.9.China Biobanks, 2014 – 2023, Historic And Forecast, By Segment
    • 14.10.India Biobanks Market
    • 14.11.India Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 14.12.India Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 14.13.India Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 14.14.Japan Biobanks Market
    • 14.15.Japan Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 14.16.Japan Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 14.17.Japan Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 14.18.Australia Biobanks Market
    • 14.19.Australia Biobanks Market, 2014-2023, Market Value ($ Millions)
    • 14.20.Australia Biobanks Market, 2018, By Segment, Value ($ Millions)
    • 14.21.Australia Biobanks, 2014 - 2023, Historic And Forecast, By Segment
  15. 15.Western Europe Biobanks Market Overview
    • 15.1.Western Europe Biobanks Market Overview
      • 15.1.1.Region Information
      • 15.1.2.Market Information
      • 15.1.3.Background Information
      • 15.1.4.Associations
      • 15.1.5.Regulation
      • 15.1.6.Regulatory Bodies
      • 15.1.7.Corporate Tax Structure
      • 15.1.8.Investments
      • 15.1.9.Major Companies
      • 15.1.10.End User Information
    • 15.2.Western Europe Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 15.3.Western Europe Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 15.4.Western Europe Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 15.5.Western Europe Biobanks Market: Country Analysis
    • 15.6.UK Biobanks Market
    • 15.7.UK Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 15.8.UK Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 15.9.UK Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 15.10.Germany Biobanks Market
    • 15.11.Germany Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 15.12.Germany Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 15.13.Germany Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 15.14.France Biobanks Market
    • 15.15.France Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 15.16.France Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 15.17.Italy Biobanks Market
    • 15.18.Italy Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 15.19.Italy Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 15.20.Italy Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 15.21.Spain Biobanks Market
    • 15.22.Spain Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 15.23.Spain Biobanks Market, 2018, By Segment, Value ($ Billion)
  16. 16.Eastern Europe Biobanks Market Overview
    • 16.1.Eastern Europe Biobanks Market Overview
      • 16.1.1.Region Information
      • 16.1.2.Market Information
      • 16.1.3.Background Information
      • 16.1.4.Associations
      • 16.1.5.Regulation
      • 16.1.6.Regulatory Bodies
      • 16.1.7.Corporate Tax Structure
      • 16.1.8.Investments
      • 16.1.9.Major Companies
      • 16.1.10.End User Information
    • 16.2.Eastern Europe Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 16.3.Eastern Europe Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 16.4.Eastern Europe Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 16.5.Eastern Europe Biobanks Market: Country Analysis
    • 16.6.Russia Biobanks Market
    • 16.7.Russia Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 16.8.Russia Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 16.9.Russia Biobanks, 2014 - 2023, Historic And Forecast, By Segment
  17. 17.North America Biobanks Market Overview
    • 17.1.North America Biobanks Market Overview
      • 17.1.1.Region Information
      • 17.1.2.Market Information
      • 17.1.3.Background Information
      • 17.1.4.Associations
      • 17.1.5.Regulation
      • 17.1.6.Regulatory Bodies
      • 17.1.7.Corporate Tax Structure
      • 17.1.8.Investments
      • 17.1.9.Major Companies
      • 17.1.10.End User Information
    • 17.2.North America Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 17.3.North America Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 17.4.North America Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 17.5.North America Biobanks Market: Country Analysis
    • 17.6.USA Biobanks Market
    • 17.7.USA Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 17.8.USA Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 17.9.USA Biobanks, 2014 - 2023, Historic And Forecast, By Segment
  18. 18.South America Biobanks Market Overview
    • 18.1.South America Biobanks Market Overview
      • 18.1.1.Region Information
      • 18.1.2.Market Information
      • 18.1.3.Background Information
      • 18.1.4.Associations
      • 18.1.5.Regulation
      • 18.1.6.Regulatory Bodies
      • 18.1.7.Corporate Tax Structure
      • 18.1.8.Investments
      • 18.1.9.Major Companies
      • 18.1.10.End User Information
    • 18.2.South America Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 18.3.South America Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 18.4.South America Biobanks, 2014 - 2023, Historic And Forecast, By Segment
    • 18.5.South America Biobanks Market: Country Analysis
    • 18.6.Brazil Biobanks Market
    • 18.7.Brazil Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 18.8.Brazil Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 18.9.Brazil Biobanks, 2014 - 2023, Historic And Forecast, By Segment
  19. 19.Middle East Biobanks Market Overview
    • 19.1.Middle East Biobanks Market Overview
      • 19.1.1.Region Information
      • 19.1.2.Market Information
      • 19.1.3.Background Information
      • 19.1.4.Associations
      • 19.1.5.Regulatory Bodies
      • 19.1.6.Corporate Tax Structure
      • 19.1.7.Investments
      • 19.1.8.Major Companies
      • 19.1.9.End User Information
    • 19.2.Middle East Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 19.3.Middle East Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 19.4.Middle East Biobanks, 2014 - 2023, Historic And Forecast, By Segment
  20. 20.Africa Biobanks Market Overview
    • 20.1.Africa Biobanks Market Overview
      • 20.1.1.Region Information
      • 20.1.2.Market Information
      • 20.1.3.Background Information
      • 20.1.4.Associations
      • 20.1.5.Tax Levied
      • 20.1.6.Regulatory Bodies
      • 20.1.7.Corporate Tax Structure
      • 20.1.8.Investments
      • 20.1.9.Major Companies
      • 20.1.10.End User Information
    • 20.2.Africa Biobanks Market, 2014-2023, Market Value ($ Billion)
    • 20.3.Africa Biobanks Market, 2018, By Segment, Value ($ Billion)
    • 20.4.Africa Biobanks, 2014 - 2023, Historic And Forecast, By Segment
  21. 21.Biobanks Market Competitive Landscape
    • 21.1.Company Profiles
    • 21.2.Japanese Red Cross Society
      • 21.2.1.Company Overview
      • 21.2.2.Financial Performance
    • 21.3.American Red Cross
      • 21.3.1.Company Overview
      • 21.3.2.Financial Performance
    • 21.4.Canadian Blood Services
      • 21.4.1.Company Overview
      • 21.4.2.Products and Services
      • 21.4.3.Financial Performance
    • 21.5.Biobank Graz
      • 21.5.1.Company Overview
    • 21.6.Shanghai Zhangjiang Biobank
      • 21.6.1.Company Overview
  22. 22.Key Mergers And Acquisitions In The Biobanks Market
    • 22.1.Grifols Acquired Minority Stake in Interstate Blood Bank
    • 22.2.Cryo-Cell International Acquired Cord: Use Cord Blood Bank
    • 22.3.BioDuro Acquired Molecular Response, LLC
    • 22.4.Roche Acquired Signature Diagnostics
    • 22.5.Lifeblood Merged With Blood Systems
  23. 23.Market Innovations
    • 23.1.Use of 3D Printing technology
    • 23.2.Digitalization of biobanks
  24. 24.Opportunities And Strategies
    • 24.1.Global Biobanks Market Opportunities
    • 24.2.Global Biobanks Market In 2023- Countries Offering Most New Opportunities
    • 24.3.Global Biobanks In 2023- Segments Offering Most New Opportunities
      • 24.3.1.Blood Products
      • 24.3.2.Cell Lines
      • 24.3.3.Human Tissues and Cells
      • 24.3.4.Nucleic Acids
    • 24.4.Global Biobanks Market Strategies In 2023 – Growth Strategies
      • 24.4.1.Market Trend Based Strategies
  25. 25.Appendix
    • 25.1.Market Data Sources
    • 25.2.Currencies
    • 25.3.Research Inquiries
    • 25.4.The Business Research Company
  26. 25.5.Copyright and Disclaimer
Dental Tourism And Adoption Of New Technology In The Dental Services Industry
Global Contract Research Organizations market | Characteristics, Forecast Size, Trends
Global Veterinary Services market | Characteristics, Forecast Size, Trends
Teletherapy: A Solution To Diagnose And Treat Patients Online
DocOn: An App For Accessing Prescription Records Online
Micro Birthing To Simulate The Infants Immune System
Mathematical Modelling For The Treatment Of Brain Diseases
Medical And Diagnostic Laboratory Services Global Market Report 2019
View Report
Physicians And Other Health Practitioners Global Market Report 2019
View Report
Ambulance Services Global Market Report 2019
View Report
Residential Substance Abuse And Mental Health Facilities Market Global Briefing 2018
View Report
Home Health Care Providers Global Market Report 2018
View Report
Diagnostic Imaging Centers Global Market Report 2018
View Report
Home Health Care And Residential Nursing Care Services Global Market Report 2018
View Report
Retirement Communities Global Market Report 2018
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)